Your browser doesn't support javascript.
loading
Virtual Cancer Care Beyond the COVID-19 Pandemic: Patient and Staff Perspectives and Recommendations.
Abdelmutti, Nazek; Powis, Melanie; Macedo, Alyssa; Liu, Zhihui; Bender, Jackie L; Papadakos, Janet; Hack, Saidah; Rajnish, Nikki; Rana, Palwasha; Kittuppanantharajah, Shay; Lovas, Mike; Melwani, Sheena; Moody, Lesley; Elliot, Mary; Ashfaq, Iqra; Avery, Lisa; Mohammed, Hiba; Berlin, Alejandro; Krzyzanowska, Monika K.
Afiliação
  • Abdelmutti N; Cancer Quality Lab (CQuaL), Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada.
  • Powis M; Cancer Digital Intelligence, Princess Margaret Cancer Centre- University Health Network, Toronto, ON, Canada.
  • Macedo A; Cancer Quality Lab (CQuaL), Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada.
  • Liu Z; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre- University Health Network, Toronto, ON, Canada.
  • Bender JL; Cancer Quality Lab (CQuaL), Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada.
  • Papadakos J; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre- University Health Network, Toronto, ON, Canada.
  • Hack S; Department of Radiation Oncology, Princess Margaret Cancer Centre- University Health Network, Toronto, ON, Canada.
  • Rajnish N; Department of Supportive Care, Princess Margaret Cancer Centre- University Health Network, Toronto, ON, Canada.
  • Rana P; Cancer Quality Lab (CQuaL), Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada.
  • Kittuppanantharajah S; Cancer Education, Princess Margaret Cancer Centre- University Health Network, Toronto, ON, Canada.
  • Lovas M; Cancer Quality Lab (CQuaL), Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada.
  • Melwani S; Cancer Quality Lab (CQuaL), Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada.
  • Moody L; Cancer Quality Lab (CQuaL), Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada.
  • Elliot M; Cancer Quality Lab (CQuaL), Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada.
  • Ashfaq I; Cancer Digital Intelligence, Princess Margaret Cancer Centre- University Health Network, Toronto, ON, Canada.
  • Avery L; Cancer Digital Intelligence, Princess Margaret Cancer Centre- University Health Network, Toronto, ON, Canada.
  • Mohammed H; Cancer Quality Lab (CQuaL), Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada.
  • Berlin A; Department of Supportive Care, Princess Margaret Cancer Centre- University Health Network, Toronto, ON, Canada.
  • Krzyzanowska MK; Cancer Quality Lab (CQuaL), Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada.
JCO Oncol Pract ; 20(5): 643-656, 2024 May.
Article em En | MEDLINE | ID: mdl-38266201
ABSTRACT

PURPOSE:

COVID-19 catalyzed rapid implementation of virtual cancer care (VC); however, work is needed to inform long-term adoption. We evaluated patient and staff experiences with VC at a large urban, tertiary cancer center to inform recommendations for postpandemic sustainment.

METHODS:

All physicians who had provided VC during the pandemic and all patients who had a valid e-mail address on file and at least one visit to the Princess Margaret Cancer Centre in Toronto, Canada, in the preceding year were invited to complete a survey. Interviews and focus groups with patients and staff across the cancer center were analyzed using qualitative descriptive analysis and triangulated with survey findings.

RESULTS:

Response rates for patients and physicians were 15% (2,343 of 15,169) and 41% (100 of 246), respectively. A greater proportion of patients than physicians were satisfied with VC (80.1 v 53.4%; P < .01). In addition, fewer patients than physicians felt that virtual visits were worse than those conducted in person (28.0 v 43.4%; P < .01) and that telephone and video visits negatively affected the human interaction that they valued (59.8% v 82.0%; P < .01). Major barriers to VC for patients were respect for care preferences and personal boundaries, accessibility, and equitable access. For staff, major barriers included a lack of role clarity, dedicated resources (space and technology), integration of nursing and allied health, support (administrative, clinical, and technical), and guidance on appropriateness of use.

CONCLUSION:

Patient and staff perceptions and barriers to virtual care are different. Moving forward, we need to pay attention to both staff and patient experiences with virtual care since this will have major implications for long-term adoption into clinical practice.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Telemedicina / COVID-19 / Neoplasias Tipo de estudo: Guideline / Qualitative_research Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: JCO Oncol Pract Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Telemedicina / COVID-19 / Neoplasias Tipo de estudo: Guideline / Qualitative_research Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: JCO Oncol Pract Ano de publicação: 2024 Tipo de documento: Article